FDA panel sets review date for Medtronic's Bryan cervical disc implant:
This article was originally published in Clinica
A US FDA advisory panel is to meet on July 17 2007 to review a second artificial cervical disc made by Medtronic, the company has reported. It will vote on whether or not to recommend that the agency approves the total disc replacement (TDR) system, called Bryan. The company's first cervical TDR product, Prestige, came before the FDA's orthopaedic and rehabilitation devices advisory panel last year, and was given a positive recommendation for approval; the FDA is expected to deliver a final verdict on the device this summer, Medtronic said. The FDA has yet to approve a cervical TDR, although lumber TDRs are already available in the US.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.